Clinical Trials Logo

Bile Duct Cancer clinical trials

View clinical trials related to Bile Duct Cancer.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04404647 Withdrawn - Clinical trials for Hepatocellular Carcinoma

Irreversible Electroporation of Unresectable Liver Tumors

Start date: June 1, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the safety and feasibility of curative intended irreversible electroporation (IRE) in the treatment of liver tumors neighboring major vessels or bile ducts.

NCT ID: NCT02446379 Withdrawn - Pancreatic Cancer Clinical Trials

Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour Surgery

CLIO
Start date: n/a
Phase: N/A
Study type: Observational

This study will evaluate the performance of the EnLightTM and LightPathTM Imaging Systems in detecting tumour lesions in patients with gastric, pancreas, bile duct or duodenal cancer. EnLightTM will be used to detect positron emission and the LightPathTM system to detect Cerenkov Luminescence. Both are emitted by the Positron Emission Tomography (PET) agent. The study will also evaluate the patient safety and radiation safety of the EnLightTM, and the safety for the device operators and surgical staff of the LightPathTM Imaging System.